search
Back to results

Serratus Anterior Plane Block for Modified Radical Mastectomy: Double-point VS Single-point

Primary Purpose

Mammary Cancer, Serratus Anterior Plane Block, Postoperative Pain

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Double-point SAPB
Single-point SAPB
Sponsored by
Fudan University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Mammary Cancer focused on measuring Mammary Cancer, Serratus Anterior Plane Block, Postoperative Pain, Axillary Discomfort

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients are proposed to undergo Modified Radical Mastectomy
  • Patients with American Society of Anesthesiologists (ASA) physical status I~III
  • aged 18-70 years
  • BMI ≤ 35 kg/m2

Exclusion Criteria:

  • Patients with a pre-existing neuropathy or sensory deficit affecting the operative region
  • Pregnancy
  • Chronic pain or opioid dependence (at least 30 mg of oxycodone or equivalent per day)
  • Allergy to local anaesthesia or any component of the proposed multimodal analgesia regimen
  • Local or systemic contra-indications to peripheral nerve blocks (local infection at the puncture site, coagulopathy, platelets less than 80*10^9/L and prothrombin time more than 15 s)

Sites / Locations

  • Fudan University Shanghai Cancer CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Double-point SAPB

Single-point SAPB

Arm Description

SAPB will be performed simultaneously in both the third and fifth rib levels.

SAPB will be performed only in the fifth rib level.

Outcomes

Primary Outcome Measures

Postoperative pain severity at 24 h
Postoperative pain severity at rest and movement measured using a numerical rating scale(NRS) at 24 h. The numerical rating scale (NRS) is a line with numbers from 0 to 10 are spaced evenly across the page. And the NRS is bounded at the left-most end with "no pain" and at the right-most end with "worst pain imaginable". Patients are instructed to circle the number that represents the amount of pain that they are experiencing at the time of the evaluation. The movement status refers to maximum mobility of the upper arm of the surgical side.

Secondary Outcome Measures

Pain severity at discharge from PACU and at 6 and 12 and 48 h postoperatively
Secondary analgesic outcomes included: pain severity at rest and movement measured using a NRS at discharge from PACU and at 6 and 12 and 48 h postoperatively;
Postoperative opioid consumption
At the end of surgery, patients use postoperative controlled analgesia pump, equip with 0.75 μg / ml sufentanil without background dose, locking time is 10min, and each controlled dose is 2 ml. The cumulative amount of sufentanil used at 24 and 48 hours after surgery will be recorded separately.
Proportion of rescue analgesia
Rescue analgesia was started when NRS ≥ 4, with Flurbiprofen Axetil 50mg i. v. The proportion of patients who required at least one rescue analgesia at 48 hours after surgery will be recorded.

Full Information

First Posted
December 6, 2021
Last Updated
March 17, 2022
Sponsor
Fudan University
search

1. Study Identification

Unique Protocol Identification Number
NCT05299021
Brief Title
Serratus Anterior Plane Block for Modified Radical Mastectomy: Double-point VS Single-point
Official Title
The Analgesic Effect of Ultrasound-guided Double-point Versus Single-point Serratus Anterior Plane Block on Modified Radical Mastectomy:A Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
December 1, 2021 (Actual)
Primary Completion Date
June 28, 2022 (Anticipated)
Study Completion Date
June 30, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Fudan University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Nowadays, the incidence of breast cancer is the first number of malignant tumors, and the primary treatment method is surgery. As is known to all, less postoperative complications and enhanced recovery are closely related to effective analgesia. However, postoperative patients often experience moderate pain, while associated with axillary discomfort. Serratus Anterior Plane Block (SAPB) relieves postoperative pain, but traditional single point block method has no effect on axillary discomfort. Therefore, it is necessary to try double point blocks to explore their impact on postoperative analgesia and axillary comfort. This RCT will recruit patients proposed to undergo Modified Radical Mastectomy (MRM) and be randomized to single point or double point groups to evaluate their postoperative pain score and axillary comfort in order to provide clinical guidance.
Detailed Description
The conventional SAPB, which often performs single point block from the level of the fifth rib, does not completely relieve postoperative pain in patients with axillary lymph node dissection, probably due to insufficient range of local anesthetic diffusion.Anatomical study indicated that with a double point SAPB at the third and fifth rib levels, respectively, the local anesthetic diffusion range can reach the axillary level and may provide better analgesic effects. However, the support of clinical data is lacking.Therefore, the hypothesis of this study is that double point SAPB will provide better postoperative analgesia compared with conventional single point SAPB in patients undergoing modified radical mastectomy.This study will include 60 patients proposed to undergo modified radical mastectomy, allocated to the Double-point or Single-point group in a 1:1 ratio, randomly.The Double-point group will perform a double point SAPB, which is a combined block at the third and fifth rib levels, respectively.The Single-point group will undergo a single point SAPB, traditionally performed at the level of the fifth rib.Observation outcomes included changes in blood pressure and heart rate during dissection of skin and dissection of axillary lymph nodes, postoperative pain scores, axillary comfort, recovery quality, and related complications and postoperative hospital stay.Therefore, the objective is to investigate whether this simple technical modification can better reduce postoperative pain and promote rehabilitation in patients with modified radical mastectomy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mammary Cancer, Serratus Anterior Plane Block, Postoperative Pain
Keywords
Mammary Cancer, Serratus Anterior Plane Block, Postoperative Pain, Axillary Discomfort

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Double-point SAPB
Arm Type
Experimental
Arm Description
SAPB will be performed simultaneously in both the third and fifth rib levels.
Arm Title
Single-point SAPB
Arm Type
Experimental
Arm Description
SAPB will be performed only in the fifth rib level.
Intervention Type
Procedure
Intervention Name(s)
Double-point SAPB
Intervention Description
After general anesthesia, patients were placed in the lateral position with 90˚ abduction of the upper arm. A high-frequency linear probe (6-13 MHz) of the ultrasound machine was used to identify the fifth rib in the midaxillary line. The anatomic landmarks of the block were identified: latissimus dorsi, serratus anterior, and the intercostal muscles in the fourth and fifth intercostal levels. After sterilization and draping, an 18-gauge needle was introduced craniocaudally at an angle of 45˚ using an in-plane technique. The needle tip was advanced, targeting the plane between the serratus anterior muscle and the fifth rib. Needle position was confirmed by injection of 1-to-2 mL of saline after negative aspiration. And use the same method targeting the plane between the serratus anterior muscle and the third rib.Under real-time visualization, total 30 mL of 0.375% ropivacaine and 1 μ g/kg dexmedetomidine mixture will be injected into the two points with 15 ml separately.
Intervention Type
Procedure
Intervention Name(s)
Single-point SAPB
Intervention Description
After general anesthesia, patients were placed in the lateral position with 90˚ abduction of the upper arm. A high-frequency linear probe (6-13 MHz) of the ultrasound machine was used to identify the fifth rib in the midaxillary line. The anatomic landmarks of the block were identified: latissimus dorsi, serratus anterior, and the intercostal muscles in the fourth and fifth intercostal levels. After sterilization and draping, an 18-gauge needle was introduced craniocaudally at an angle of 45˚ using an in-plane technique. The needle tip was advanced, targeting the plane between the serratus anterior muscle and the fifth rib. Needle position was confirmed by injection of 1-to-2 mL of saline after negative aspiration.Under real-time visualization, total 30 mL of 0.375% ropivacaine and 0.5μ g/kg dexmedetomidine mixture will be injected.
Primary Outcome Measure Information:
Title
Postoperative pain severity at 24 h
Description
Postoperative pain severity at rest and movement measured using a numerical rating scale(NRS) at 24 h. The numerical rating scale (NRS) is a line with numbers from 0 to 10 are spaced evenly across the page. And the NRS is bounded at the left-most end with "no pain" and at the right-most end with "worst pain imaginable". Patients are instructed to circle the number that represents the amount of pain that they are experiencing at the time of the evaluation. The movement status refers to maximum mobility of the upper arm of the surgical side.
Time Frame
24 hours after the surgery
Secondary Outcome Measure Information:
Title
Pain severity at discharge from PACU and at 6 and 12 and 48 h postoperatively
Description
Secondary analgesic outcomes included: pain severity at rest and movement measured using a NRS at discharge from PACU and at 6 and 12 and 48 h postoperatively;
Time Frame
Respectively at discharge from PACU and at 6 and 12 and 48 h after the surgery;
Title
Postoperative opioid consumption
Description
At the end of surgery, patients use postoperative controlled analgesia pump, equip with 0.75 μg / ml sufentanil without background dose, locking time is 10min, and each controlled dose is 2 ml. The cumulative amount of sufentanil used at 24 and 48 hours after surgery will be recorded separately.
Time Frame
Respectively at 24 and 48 h after the surgery;
Title
Proportion of rescue analgesia
Description
Rescue analgesia was started when NRS ≥ 4, with Flurbiprofen Axetil 50mg i. v. The proportion of patients who required at least one rescue analgesia at 48 hours after surgery will be recorded.
Time Frame
48 h after the surgery;
Other Pre-specified Outcome Measures:
Title
Postoperative axillary comfort severity
Description
Referring to the pain numerical rating scale, make the axillary comfort numerical rating scale. An integer of 0 to 10 is used to indicate different levels of axillary discomfort, and "0" is "no discomfort", and "10" is the "most severe axillary discomfort".Patients are instructed to circle the number that represents the amount of axillary comfort that they are experiencing at the time of the evaluation.
Time Frame
Respectively at discharge from PACU and at 6 and 12 and 24 and 48 h after the surgery.
Title
Postoperative quality of recovery
Description
Quality of recovery (QoR) after the surgery will be assessed using a Quality of recovery 15 (QoR-15) scale. This scale is a self-rated patient-centered system for the assessment of the quality of early postoperative recovery, including five dimensions: emotional state, physical comfort, psychological support, physiological independence and pain, with 15 items and scores ranging from 0 to 150, and higher scores indicate a better quality of postoperative recovery.
Time Frame
Respectively at 24 and 48 h after the surgery.
Title
Changes in mean arterial pressure(MAP) and heart rate during skin peeling and axillary node dissection
Description
Perfect analgesia can reduce the effect of surgical stimulation on heart rate and MAP. Surgical stimulation increases at the onset of peeling or the dissection of the axillary lymph nodes, when the magnitude of changes in MAP and heart rate can indirectly reflect the degree of analgesia.MAP and heart rate will be therefore recorded before and after 3 min of incision, before and after 3 min of axillary lymph nodes respectively.
Time Frame
Before and after 3 min of incision, before and after 3 min of axillary lymph nodes,respectively.
Title
Proportion of postoperative nausea and vomiting
Description
Proportion of patients experiencing postoperative nausea and vomiting at least once at 48 h postoperatively.
Time Frame
up to 48 hours postoperatively.

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Breast cancer patients
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients are proposed to undergo Modified Radical Mastectomy Patients with American Society of Anesthesiologists (ASA) physical status I~III aged 18-70 years BMI ≤ 35 kg/m2 Exclusion Criteria: Patients with a pre-existing neuropathy or sensory deficit affecting the operative region Pregnancy Chronic pain or opioid dependence (at least 30 mg of oxycodone or equivalent per day) Allergy to local anaesthesia or any component of the proposed multimodal analgesia regimen Local or systemic contra-indications to peripheral nerve blocks (local infection at the puncture site, coagulopathy, platelets less than 80*10^9/L and prothrombin time more than 15 s)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jun Zhang, PhD
Phone
86-21-64175590
Email
snapzhang@aliyun.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jun Zhang, PhD
Organizational Affiliation
Fudan University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fudan University Shanghai Cancer Center
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
200032
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jun Zhang, PhD
Phone
+86-21-64175590
Email
snapzhang@aliyun.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Serratus Anterior Plane Block for Modified Radical Mastectomy: Double-point VS Single-point

We'll reach out to this number within 24 hrs